Administrative Core
Administrative Core
批准号:
8202353
负责人:
KEITH R JEROME
金额:
$24.45万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-07-08 至 2016-06-30
关键词:
Administrative CoordinationAutologousAutologous TransplantationBerlinCCR5 geneCD34 geneCD4 Positive T LymphocytesCellsChildCitiesClinicalCommunicationCommunitiesComplexDNAEnsureEthicsFred Hutchinson Cancer Research CenterGoalsHIVHIV InfectionsHomingHuman ResourcesIndividualInstitutionLaboratoriesMacacaMacaca nemestrinaMethodsPathway interactionsPerformance at workPeripheral Blood Mononuclear CellPhylogenetic AnalysisPrivate SectorProceduresProvirusesRegimenResearchResearch PersonnelScientistServicesSiteSite-Directed MutagenesisStem cell transplantStem cellsStructureTestingTimeTransgenesTransplantationUnited States National Institutes of HealthUniversitiesWashingtonZinc Fingersbaseconditioningdesignendonucleaseexperiencemembernonhuman primatenucleaseprogramspurgeresearch studysimian human immunodeficiency virussuccess
中文摘要
在这个U19应用程序中,我们建议建立我们在非人灵长类动物干细胞移植方面的专业知识
英文摘要
In this U19 application we propose to build upon our expertise in nonhuman primate stem cell transplantation
(pigtail macaques), and carefully evaluate the effects of pretransplant conditioning regimens on the HIV
reservoir. Our private sector partner will develop ZFNs capable of modifying the macaque CCR5 locus, and
optimize methods for their delivery to CD34[+] stem cells. Combining these efforts, we will then perform
autologous transplantation in macaques using the CCR5-modfied stem cells. In this way, we hope to
recapitulate the well-known Berlin experiment, but using autologous cells such that this approach could be
applied to the vast majority of HIV-infected individuals who do not have matched CCR5A32 donors. At the
same time, we will develop SHIV-specific homing endonucleases that can directly modify proviral sequences
within infected cells (rendering the provirus nonfunctional), and optimize methods for delivery of these HEs to
CD4+ T cells and to CD34+ stem cells. We will then test the ability of these HEs to purge provirus from
infected cells, using PBMC and stem cells obtained from the macaques in our transplant studies.
This is a complex and highly interactive program bringing together experts in multiple fields. Thus, a strong
administrative structure is critical to the successful performance of this work. The aims of the core are:
SA1. Ensure that the U19 functions efficiently using effective administrative, fiscal, and scientific
review procedures.
SA2. Ensure that the U19 investigators communicate effectively with each other, with the broader
scientific and clinical communities, with other collaborators, and with the program sponsor, NIH.
SAS. Ensure that investigators in the U19 adhere to the highest ethical standards in conducting
their research.
The Administrative Core will coordinate the administrative, fiscal and organizational aspects of our U19
program, will facilitate scientific communication, and will provide fixed support services to each of the
projects and cores. Our integrated research program includes leading scientists based at the FHCRC, the
UW, Seattle Children's, City of Hope, and Sangamo Biosciences. Administrative staff members in the Core
will provide a bridge between these institutions. All are experienced in coordination of the administrative
complexities that a combined program creates.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Endonuclease-mediated disruption of latent HSV as curative therapy
-
批准号:10182099
-
项目类别:
-
资助金额:$44.0万
-
财政年份:2018
-
负责人:KEITH R JEROME
-
依托单位:
Endonuclease-mediated disruption of latent HSV as curative therapy
-
批准号:10155424
-
项目类别:
-
资助金额:$28.28万
-
财政年份:2018
-
负责人:KEITH R JEROME
-
依托单位:
Endonuclease-mediated disruption of latent HSV as curative therapy
-
批准号:9597105
-
项目类别:
-
资助金额:$45.01万
-
财政年份:2018
-
负责人:KEITH R JEROME
-
依托单位:
Endonuclease-mediated disruption of latent HSV as curative therapy
-
批准号:10405036
-
项目类别:
-
资助金额:$43.77万
-
财政年份:2018
-
负责人:KEITH R JEROME
-
依托单位:
Endonuclease-mediated disruption of latent HSV as curative therapy
-
批准号:9927580
-
项目类别:
-
资助金额:$43.78万
-
财政年份:2018
-
负责人:KEITH R JEROME
-
依托单位:
Endonuclease-mediated disruption of latent HSV as curative therapy
-
批准号:10593355
-
项目类别:
-
资助金额:$15.5万
-
财政年份:2018
-
负责人:KEITH R JEROME
-
依托单位:
In vivo inactivation of latent HSV by endonuclease-mediated mutagenesis
-
批准号:9199202
-
项目类别:
-
资助金额:$22.0万
-
财政年份:2016
-
负责人:KEITH R JEROME
-
依托单位:
Cell and Gene Therapy for HIV Cure
-
批准号:9191169
-
项目类别:
-
资助金额:$471.5万
-
财政年份:2016
-
负责人:KEITH R JEROME
-
依托单位:
Cell and Gene Therapy for HIV Cure
-
批准号:10593375
-
项目类别:
-
资助金额:$40.73万
-
财政年份:2016
-
负责人:KEITH R JEROME
-
依托单位:
In vivo inactivation of latent HSV by endonuclease-mediated mutagenesis
-
批准号:9035463
-
项目类别:
-
资助金额:$26.4万
-
财政年份:2016
-
负责人:KEITH R JEROME
-
依托单位:
Targeted Modification of Host and Proviral DNA to Treat Latent HIV Infection
-
批准号:8691703
-
项目类别:
-
资助金额:$406.88万
-
财政年份:2011
-
负责人:KEITH R JEROME
-
依托单位:
Targeted Disruption of Integrated SHIV by Engineered Homing Endonucleases
-
批准号:8202339
-
项目类别:
-
资助金额:$58.68万
-
财政年份:2011
-
负责人:KEITH R JEROME
-
依托单位:
Targeted Modification of Host and Proviral DNA to Treat Latent HIV Infection
-
批准号:8876542
-
项目类别:
-
资助金额:$437.13万
-
财政年份:2011
-
负责人:KEITH R JEROME
-
依托单位:
Targeted Modification of Host and Proviral DNA to Treat Latent HIV Infection
-
批准号:8185379
-
项目类别:
-
资助金额:$393.21万
-
财政年份:2011
-
负责人:KEITH R JEROME
-
依托单位:
Targeted Modification of Host and Proviral DNA to Treat Latent HIV Infection
-
批准号:8299007
-
项目类别:
-
资助金额:$403.38万
-
财政年份:2011
-
负责人:KEITH R JEROME
-
依托单位:
Targeted Modification of Host and Proviral DNA to Treat Latent HIV Infection
-
批准号:8497599
-
项目类别:
-
资助金额:$437.51万
-
财政年份:2011
-
负责人:KEITH R JEROME
-
依托单位:
Mechanisms of Inactivation of T Cells by HSV
-
批准号:7216524
-
项目类别:
-
资助金额:$38.71万
-
财政年份:2006
-
负责人:KEITH R JEROME
-
依托单位:
Inactivation of CTL by HSV-infected cells
-
批准号:6811469
-
项目类别:
-
资助金额:$25.95万
-
财政年份:2004
-
负责人:KEITH R JEROME
-
依托单位:
Inactivation of CTL by HSV-infected cells
-
批准号:6929273
-
项目类别:
-
资助金额:$21.63万
-
财政年份:2004
-
负责人:KEITH R JEROME
-
依托单位:
Inhibition of CTL killing by HSV
-
批准号:6732169
-
项目类别:
-
资助金额:$25.95万
-
财政年份:2001
-
负责人:KEITH R JEROME
-
依托单位:
海外基金